An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool

NCT ID: NCT07120191

Last Updated: 2025-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone total joint replacement as a post-op communication tool. Data will be collected on how effectively the product guides patients through their recovery, identifying potential complications, and providing appropriate recommendations based on structured question pairs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who are scheduled to undergo orthopedic total hip or total knee replacement surgery who meet the eligibility criteria will be enrolled in the study. Prior to surgery, participants will be trained on the use of the product and study requirements will be discussed. The training provides instructions at an in-office visit, outlining the device's usage. The instructions, along with warnings that the interface is with a computer and not a person, are emphasized in the device's app and user manual.

Daily prompts will interact with the patient, and the app will answer questions and direct specialized care/instructions. Participants will be instructed to engage with the software throughout the 30-day study period, responding to prompts and questions as the participant recovers from surgery. The software will log and archive all participants' interactions with the chatbot in the backend. Participants will be expected to utilize the investigational product after discharge and complete the 30-day study period.

For every active participant enrolled, a retrospective chart review patient from the same site will be enrolled in the study in a 1:1 manner. The retrospective review of approximately 200 patient's post-op clinical interactions will be collected as a control group for comparison.

An initial technical assessment of the application will be done with the first 10 active patients who have used the product for at least 2 weeks, focusing on the overall performance of the communication tool.

The primary objective of the study is to collect a structured conversation log, document product's decision-making patterns, and to ensure sufficient coverage of clinical scenarios.

Beyond the AI-driven conversation, the product will collect daily health characteristics on pain, sleep, activity levels, medication use, and diet. Pain reporting is captured through two distinct input methods: the GRASP® device, a trademarked handheld event marker used to record three distinct pain levels, and a smartphone-based slider, allowing for subjective pain self-reporting. The participant may choose either input method, both will be encouraged.

Additional product components include chat functionality and the provider dashboard.

Chat function will collect data for responsiveness, clarity, and patient engagement, ensuring it facilitates a smooth and intuitive post-operative communication experience. The provider dashboard will collect usability and functionality data, as it mirrors the patient's application while also allowing providers to manage office setup, input new patients, confirm surgical dates, and conduct real-time chat interactions with patients.

Both patient and provider satisfaction of the use of My Connect Post-Op Software will be collected periodically throughout the 30-day post-op period as noted in the Schedule of Activities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Replacement Total Knee Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults undergoing total hip or knee replacement surgery

The entire active group will be utilizing the MyConnect Post Op communication tool.

post op communication software

Intervention Type DEVICE

MyConnect Post Op is a communication tool that utilizes Technology Assisted Conversation to aid in the recovery of total knee and hip replacement patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

post op communication software

MyConnect Post Op is a communication tool that utilizes Technology Assisted Conversation to aid in the recovery of total knee and hip replacement patients

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MyConnect Post Op

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Orthopedic patients scheduled for elective joint arthroplasty (single or double knee, or single or double hip replacement surgery).

Age 22-80 years. Owns a smart phone. Speaks and understands written and spoken English. Ability to give written informed consent.

Exclusion Criteria

Known diagnosis of a psychiatric disorder. Known opioid dependence in the Investigator's opinion that may complicate participation.

Participation in another clinical trial investigating a drug, medical device, or a medical procedure in the 30 days preceding trial inclusion and throughout the duration of the trial.

Any condition that in the Investigator's opinion may complicate or preclude the subject from participating in this trial, such as physical impairment or noncooperation
Minimum Eligible Age

22 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Concentra AI, inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kansas Joint and Spine

Wichita, Kansas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shonna Rexroat-Hett, RN

Role: primary

316-207-8657

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCAI-PostOp-2025-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TracPatch in Total Knee Arthroplasty
NCT03466476 ACTIVE_NOT_RECRUITING NA